Long-term results of induction chemotherapy for non-operable esophageal squamous cell carcinoma followed by concurrent chemoradiotherapy: a single-centre experience

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics 2021. CA Cancer J Clin 2021; 71: 7–33. doi: 10.3322/caac.21654 SiegelRL MillerKD FuchsHE JemalA Cancer statistics 2021 CA Cancer J Clin 2021 71 7 33 10.3322/caac.21654 Open DOISearch in Google Scholar

2. Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, et al. Oesophageal cancer. Nat Rev Dis Primers 2017; 3: 17048. doi: 10.1038/nrdp.2017.48 SmythEC LagergrenJ FitzgeraldRC LordickF ShahMA LagergrenP Oesophageal cancer Nat Rev Dis Primers 2017 3 17048 10.1038/nrdp.2017.48 Open DOISearch in Google Scholar

3. Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015; 64: 381–7. doi: 10.1136/gutjnl-2014-308124 ArnoldM SoerjomataramI FerlayJ FormanD Global incidence of oesophageal cancer by histological subtype in 2012 Gut 2015 64 381 7 10.1136/gutjnl-2014-308124 Open DOISearch in Google Scholar

4. Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet 2017; 390: 2383–96. doi: 10.1016/S0140-6736(17)31462-9 LagergrenJ SmythE CunninghamD LagergrenP Oesophageal cancer Lancet 2017 390 2383 96 10.1016/S0140-6736(17)31462-9 Open DOISearch in Google Scholar

5. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson Jr JA, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 281: 1623–7. doi: 10.1001/jama.281.17.1623 CooperJS GuoMD HerskovicA MacdonaldJS MartensonJAJr Al-SarrafM Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 1999 281 1623 7 10.1001/jama.281.17.1623 Open DOISearch in Google Scholar

6. Gwynne S, Hurt C, Evans M, Holden C, Vout L, Crosby T. Definitive chemoradiation for oesophageal cancer: a standard of care in patients with non-metastatic oesophageal cancer. Clin Oncol 2011; 23: 182–8. doi: 10.1016/j.clon.2010.12.001 GwynneS HurtC EvansM HoldenC VoutL CrosbyT Definitive chemoradiation for oesophageal cancer: a standard of care in patients with non-metastatic oesophageal cancer Clin Oncol 2011 23 182 8 10.1016/j.clon.2010.12.001 Open DOISearch in Google Scholar

7. Xi M, Xu C, Liao ZX, Hofstetter WL, Murphy MB, Maru DM, et al. The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol 2017; 124: 318–24. doi: 10.1016/j.radonc.2017.06.019 XiM XuC LiaoZX HofstetterWL MurphyMB MaruDM The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy Radiother Oncol 2017 124 318 24 10.1016/j.radonc.2017.06.019 Open DOISearch in Google Scholar

8. Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, et al. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 2014; 32: 3400–5. doi: 10.1200/JCO.2014.56.7156 SudoK XiaoL WadhwaR ShiozakiH ElimovaE TaketaT Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer J Clin Oncol 2014 32 3400 5 10.1200/JCO.2014.56.7156 Open DOISearch in Google Scholar

9. Liu SL, Luo LL, Zhao L, Zhu YJ, Liu H, Li QQ, et al. Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial. Nat Commun 2021; 12: 4014. doi: 10.1038/s41467-021-24288-1 LiuSL LuoLL ZhaoL ZhuYJ LiuH LiQQ Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial Nat Commun 2021 12 4014 10.1038/s41467-021-24288-1 Open DOISearch in Google Scholar

10. Sun Y, Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomized controlled trial. Lancet Oncol 2016; 17: 1509–20. doi: 10.1016/S1470-2045(16)30410-7 SunY LiWF ChenNY ZhangN HuGQ XieFY Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomized controlled trial Lancet Oncol 2016 17 1509 20 10.1016/S1470-2045(16)30410-7 Open DOISearch in Google Scholar

11. Chen MQ, Lin QL, Chen YG, Guo JH, Xu BH, Tian Y. Neoadjuvant chemotherapy may not benefit esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. J Chin Med Assoc 2017; 80: 636. doi: 10.1016/j.jcma.2017.06.014 ChenMQ LinQL ChenYG GuoJH XuBH TianY Neoadjuvant chemotherapy may not benefit esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy J Chin Med Assoc 2017 80 636 10.1016/j.jcma.2017.06.014 Open DOISearch in Google Scholar

12. Luo LL, Xi M, Yang YD, Li QQ, Zhao L, Zhang P, et al. Comparative outcomes of induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma. J Cancer 2017; 8: 3441–7. doi: 10.7150/jca.21131 LuoLL XiM YangYD LiQQ ZhaoL ZhangP Comparative outcomes of induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma J Cancer 2017 8 3441 7 10.7150/jca.21131 Open DOISearch in Google Scholar

13. Akinori M, Michitaka H, Yousuke I, Tsuyoshi K, Tairo R, Gencho K, et al. Induction chemotherapy followed by chemoradiotherapy for T4M0 esophageal cancer. Esophagus 2011; 8: 31–7. doi: 10.1007/s10388-011-0255-y AkinoriM MichitakaH YousukeI TsuyoshiK TairoR GenchoK Induction chemotherapy followed by chemoradiotherapy for T4M0 esophageal cancer Esophagus 2011 8 31 7 10.1007/s10388-011-0255-y Open DOISearch in Google Scholar

14. Jin J, Liao ZX, Zhang Z, Ajani J, Swisher S, Chang JY, et al. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004; 60: 427–36. doi: 10.1016/j.ijrobp.2004.03.033 JinJ LiaoZX ZhangZ AjaniJ SwisherS ChangJY Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery Int J Radiat Oncol Biol Phys 2004 60 427 36 10.1016/j.ijrobp.2004.03.033 Open DOISearch in Google Scholar

15. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, et al. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 2006; 107: 967–74. doi: 10.1002/cncr.22077 MalaisrieSC HofstetterWL CorreaAM AjaniJA KomakiRR RiceDC The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma Cancer 2006 107 967 74 10.1002/cncr.22077 Open DOISearch in Google Scholar

16. Li C, Wang X, Wang L, Chen JQ, Zhang WC, Pang QS, et al. Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey. Acta Oncologica 2021; 60: 627–34. doi: 10.1080/0284186X.2021.1902564 LiC WangX WangL ChenJQ ZhangWC PangQS Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey Acta Oncologica 2021 60 627 34 10.1080/0284186X.2021.1902564 Open DOISearch in Google Scholar

17. Lyu B, Yin YT, Zhao YL, Yang X, Gong J, Zhang M, et al. Long-term clinical outcomes and safety analysis of superficial esophageal cancer patients treated with definitive or adjuvant radiotherapy. Cancers 2022; 14: 3423. doi: 10.3390/cancers14143423 LyuB YinYT ZhaoYL YangX GongJ ZhangM Long-term clinical outcomes and safety analysis of superficial esophageal cancer patients treated with definitive or adjuvant radiotherapy Cancers 2022 14 3423 10.3390/cancers14143423 Open DOISearch in Google Scholar

18. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228–47. doi: 10.1016/j.ejca.2008.10.026 EisenhauerEA TherasseP BogaertsJ SchwartzLH SargentD FordR New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1) Eur J Cancer 2009 45 228 47 10.1016/j.ejca.2008.10.026 Open DOISearch in Google Scholar

19. Wang JN, Xiao LL, Wang S, Pang QS, Wang J. Addition of induction or consolidation chemotherapy in definitive concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone for patients with unresectable esophageal cancer: a systematic review and meta-analysis. Front Oncol 2021; 11: 665231. doi: 10.3389/fonc.2021.665231 WangJN XiaoLL WangS PangQS WangJ Addition of induction or consolidation chemotherapy in definitive concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone for patients with unresectable esophageal cancer: a systematic review and meta-analysis Front Oncol 2021 11 665231 10.3389/fonc.2021.665231 Open DOISearch in Google Scholar

20. Wu HS, Yu YL, Zheng QH, Liu TX, Wu YH, Wang ZP, et al. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma. Radiat Oncol 2021; 16: 1–14. doi: 10.1186/s13014-021-01931-1 WuHS YuYL ZhengQH LiuTX WuYH WangZP Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma Radiat Oncol 2021 16 1 14 10.1186/s13014-021-01931-1 Open DOISearch in Google Scholar

21. Hsieh JCH, Chiang PC, Hung TM, Chao YK, Kuo YC, Wen CT, et al. Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5-fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real-world evidence. Cancer Med 2021; 10: 8300–9. doi: 10.1002/cam4.4025 HsiehJCH ChiangPC HungTM ChaoYK KuoYC WenCT Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5-fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real-world evidence Cancer Med 2021 10 8300 9 10.1002/cam4.4025 Open DOISearch in Google Scholar

22. Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ, et al. Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. Int J Radiat Oncol Biol Phys 2011; 81: 813–8. doi: 10.1016/j.ijrobp.2010.12.005 SherDJ PosnerMR TishlerRB SarlisNJ HaddadRI HolupkaEJ Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324 Int J Radiat Oncol Biol Phys 2011 81 813 8 10.1016/j.ijrobp.2010.12.005 Open DOISearch in Google Scholar

23. Cannon DM, Geye HM, Hartig GK, Traynor AM, Hoang T, McCulloch TM, et al. Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy. Head Neck 2014; 36: 1120–5. doi: 10.1002/hed.23419 CannonDM GeyeHM HartigGK TraynorAM HoangT McCullochTM Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy Head Neck 2014 36 1120 5 10.1002/hed.23419 Open DOISearch in Google Scholar

24. Xu C, Xi M, Moreno A, Shiraishi Y, Hobbs BP, Huang ML, et al. Definitive chemoradiation therapy for esophageal cancer in the elderly: clinical outcomes for patients exceeding 80 years old. Int J Radiat Oncol Biol Phys 2017; 98: 811–9. doi: 10.1016/j.ijrobp.2017.02.097 XuC XiM MorenoA ShiraishiY HobbsBP HuangML Definitive chemoradiation therapy for esophageal cancer in the elderly: clinical outcomes for patients exceeding 80 years old Int J Radiat Oncol Biol Phys 2017 98 811 9 10.1016/j.ijrobp.2017.02.097 Open DOISearch in Google Scholar

25. Cai YL, Lin YX, Jiang LS, Ye H, Li FY, Cheng NS. A novel nomogram predicting distant metastasis in T1 and T2 gallbladder cancer: a SEER-based study. Int J Med Sci 2020; 17: 1704–12. doi: 10.7150/ijms.47073 CaiYL LinYX JiangLS YeH LiFY ChengNS A novel nomogram predicting distant metastasis in T1 and T2 gallbladder cancer: a SEER-based study Int J Med Sci 2020 17 1704 12 10.7150/ijms.47073 Open DOISearch in Google Scholar

26. Colzani E, Johansson ALV, Liljegren A, Foukakis T, Clements M, Adolfsson J, et al. Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics. Br J Cancer 2014; 110: 1378–84. doi: 10.1038/bjc.2014.5 ColzaniE JohanssonALV LiljegrenA FoukakisT ClementsM AdolfssonJ Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics Br J Cancer 2014 110 1378 84 10.1038/bjc.2014.5 Open DOISearch in Google Scholar

27. Hemminki K, Pavlidis N, Tsilidis KK, Sundquist K, Ji J. Age-dependent metastatic spread and survival: Cancer of unknown primary as a model. Sci Rep 2016; 6: 23725. doi: 10.1038/srep23725 HemminkiK PavlidisN TsilidisKK SundquistK JiJ Age-dependent metastatic spread and survival: Cancer of unknown primary as a model Sci Rep 2016 6 23725 10.1038/srep23725 Open DOISearch in Google Scholar

28. Kumabe A, Zenda S, Motegi A, Onozawa M, Nakamura N, Kojima T, et al. Long-term clinical results of concurrent chemoradiotherapy for patients with cervical esophageal squamous cell carcinoma. Anticancer Res 2017; 37: 5039–44. doi: 10.21873/anticanres.11919 KumabeA ZendaS MotegiA OnozawaM NakamuraN KojimaT Long-term clinical results of concurrent chemoradiotherapy for patients with cervical esophageal squamous cell carcinoma Anticancer Res 2017 37 5039 44 10.21873/anticanres.11919 Open DOISearch in Google Scholar

29. Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg RJ, Pajak T, et al. Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1999; 43: 517–23. doi: 10.1016/s0360-3016(98)00463-5 MinskyBD NeubergD KelsenDP PisanskyTM GinsbergRJ PajakT Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 1999 43 517 23 10.1016/s0360-3016(98)00463-5 Open DOISearch in Google Scholar

30. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915–21. doi: 10.1200/JCO.1999.17.9.2915 OhtsuA BokuN MuroK ChinK MutoM YoshidaS Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus J Clin Oncol 1999 17 2915 21 10.1200/JCO.1999.17.9.2915 Open DOISearch in Google Scholar

31. Shinoda M, Ando N, Kato K, Ishikura S, Kato H, Tsubosa Y, et al. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303). Cancer Sci 2015; 106: 407–12. doi: 10.1111/cas.12622 ShinodaM AndoN KatoK IshikuraS KatoH TsubosaY Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303) Cancer Sci 2015 106 407 12 10.1111/cas.12622 Open DOISearch in Google Scholar

32. Chan C, Lang S, Rowbottom C, Guckenberger M, Faivre-Finn C. Intensity-modulated radiotherapy for lung cancer: current status and future developments. J Thorac Oncol 2014; 9: 1598–608. doi: 10.1097/JTO.0000000000000346 ChanC LangS RowbottomC GuckenbergerM Faivre-FinnC Intensity-modulated radiotherapy for lung cancer: current status and future developments J Thorac Oncol 2014 9 1598 608 10.1097/JTO.0000000000000346 Open DOISearch in Google Scholar